We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA: Use of Off-Label, Unauthorized Medicines for Children Needs Attention
EMA: Use of Off-Label, Unauthorized Medicines for Children Needs Attention
February 16, 2011
The widespread use of off-label and unauthorized medicines to treat children in Europe requires regulatory review, according to a report published by the European Medicines Agency (EMA). Includes the full text of the EMA Report on All Pediatric Uses Of Medicinal Products in Europe.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor